Caricamento...
Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients
In clinical trials and meta-analysis, atherosclerotic vascular events (AVEs) during treatment with immune-checkpoint inhibitors (ICIs) have been reported with low incidence. However, preclinical data suggest that these drugs can promote atherosclerosis inflammation and progression of atherosclerosis...
Salvato in:
| Pubblicato in: | Front Cardiovasc Med |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193098/ https://ncbi.nlm.nih.gov/pubmed/34124192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.652186 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|